We are live on ! Find out more
ABCL icon

AbCellera Biologics

114 hedge funds and large institutions have $1.99B invested in AbCellera Biologics in 2021 Q2 according to their latest regulatory filings, with 48 funds opening new positions, 50 increasing their positions, 8 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

525% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 8

140% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 20

43% more call options, than puts

Call options by funds: $32.1M | Put options by funds: $22.5M

33% more funds holding

Funds holding: 86114 (+28)

20% more funds holding in top 10

Funds holding in top 10: 56 (+1)

6.61% more ownership

Funds ownership: 26.81%33.42% (+6.6%)

18% less capital invested

Capital invested by funds: $2.42B → $1.99B (-$431M)

Holders
114
Holders Change
+28
Holders Change %
+32.56%
% of All Funds
1.98%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.1%
New
48
Increased
50
Reduced
8
Closed
20
Calls
$32.1M
Puts
$22.5M
Net Calls
+$9.59M
Net Calls Change
+$8.66M
Name Holding Trade Value Shares
Change
Change in
Stake
AWE
126
Avidian Wealth Enterprises
Texas
-$441K -13,000 Closed
Walleye Capital
127
Walleye Capital
New York
-$360 -10,593 Closed
CCM
128
CAAS Capital Management
New York
-$340K -10,000 Closed
PA
129
Paragon Advisors
Texas
-$300K -8,840 Closed
LFM
130
Lumina Fund Management
New York
-$102K -3,000 Closed
Deutsche Bank
131
Deutsche Bank
Germany
-$81K -2,395 Closed
FIA
132
FNY Investment Advisers
New York
-$20K -602 Closed
QT
133
Quantbot Technologies
New York
-$14K -435 Closed
SFS
134
Sowell Financial Services
Arkansas
-$5K -166 Closed